LH · 10-Q · 2026Q2 · Full report
Revenue Performance and Mix
LABCORP HOLDINGS INC. · 2026-08-05 · Importance 43 · Surprise 32 · From source text
Second-quarter 2026 revenue increased 5.8% year over year to $3,731.1 million from $3,527.3 million, driven by 4.2% organic growth, 1.2% net acquisition growth, and 0.4% favorable foreign currency translation. Dx revenue rose 5.5% to $2,900.7 million, with requisitions up 3.0% and price/mix up 2.5%. BLS revenue increased 6.5% to $836.2 million, reflecting 6.2% organic growth and 1.8% favorable currency translation, partly offset by a 1.4% impact from strategic actions in ED. Six-month revenue rose 5.8% to $7,268.7 million, led by 5.3% Dx growth and 7.3% BLS growth.
Key facts
- For the three months ended June 30, 2026, the Company’s revenues were $3,731.1, an increase of 5.8% from $3,527.3 for the corresponding period in 2025. source
- For the six months ended June 30, 2026, the Company’s revenues were $7,268.7, an increase of 5.8% from $6,872.4 for the corresponding period in 2025. source
- Dx revenues for the three months ended June 30, 2026, were $2,900.7, an increase of 5.5% over $2,748.8 in the second quarter of 2025. source
- For the six months ended June 30, 2026, Dx revenues were $5,662.8, an increase of 5.3% over $5,378.4 during the six months ended June 30, 2025. source
- BLS revenues for the six months ended June 30, 2026, were $1,616.8, an increase of 7.3% over $1,506.1 for the six months ended June 30, 2025. source
- BLS revenues for the three months ended June 30, 2026, were $836.2, an increase of 6.5% over $784.8 in the second quarter of 2025. source
- The 5.8% increase for the three months ended June 30, 2026, was primarily due to organic revenue of 4.2%, acquisitions, net of divestitures, of 1.2%, and favorable foreign currency translation of 0.4%. source
- The 5.8% increase for the six months ended June 30, 2026, was due to organic revenue of 3.6%, acquisitions, net of divestitures, of 1.3%, and favorable foreign currency translation of 0.9%. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +10.6% | For the six months ended June 30, 2026, the Company’s revenues were $7,268.7, an increase of 5.8% from $6,872.4 for the corresponding… |
| revenue | positive | realized | +7.6% | For the six months ended June 30, 2026, Dx revenues were $5,662.8, an increase of 5.3% over $5,378.4 during the six months ended June 30,… |
| revenue | positive | realized | +5.5% | For the three months ended June 30, 2026, the Company’s revenues were $3,731.1, an increase of 5.8% from $3,527.3 for the corresponding… |
| revenue | positive | realized | +4.1% | Dx revenues for the three months ended June 30, 2026, were $2,900.7, an increase of 5.5% over $2,748.8 in the second quarter of 2025. |
| revenue | positive | realized | +3.0% | BLS revenues for the six months ended June 30, 2026, were $1,616.8, an increase of 7.3% over $1,506.1 for the six months ended June 30,… |
| revenue | positive | realized | +1.4% | BLS revenues for the three months ended June 30, 2026, were $836.2, an increase of 6.5% over $784.8 in the second quarter of 2025. |